Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer. A Phase III Randomized Controlled Trial

NCT05451004 is registered in ClinicalTrials.gov with Canadian Cancer Trials Group as lead sponsor.

NCT NCT05451004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05451004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer. A Phase III Randomized Controlled Trial
Lead sponsor
Canadian Cancer Trials Group
Phase
Phase 3
Overall status
Recruiting
Start date
February 10, 2023
Completion date
August 30, 2031
Enrollment
510 (estimated)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

oropharyngeal cancer